NDC 71872-7324-01 - Cleocin Phosphate
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 71872-7324
- Requested NDC
- 71872-7324-01
- Package NDCs from labels
- 71872-7324-1, 71872-7324-01
- Manufacturer
- Medical Purchasing Solutions, LLC
- Effective date
- 2024-03-05
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Cleocin Phosphate - Medical Purchasing Solutions, LLC | Medical Purchasing Solutions, LLC | 2024-03-05 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 71872-7324-1 | Cleocin Phosphate | 2 mL in 1 VIAL | INJECTION, SOLUTION | 2 | 1 | |
| 71872-7324-1 | Cleocin Phosphate | 1 in 1 BAG | INJECTION, SOLUTION | 1 | 1 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 71872-7324 | CLEOCIN PHOSPHATE (CLINDAMYCIN PHOSPHATE) INJECTION, SOLUTION [MEDICAL PURCHASING SOLUTIONS, LLC] | 1 | Current NDC, 2 package rows | 20240307_12ee0720-9979-3162-e063-6394a90a8003.zip |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Clindamycin in 5 Percent Dextrose | CLINDAMYCIN IN 5 PERCENT DEXTROSE | Civica, Inc. | 80217bd6-2bc4-401c-9345-22532b36a24f | 2026-04-24 | Boxed warning, Warnings, Adverse reactions | 309336 309335 |
| Clindamycin Phosphate | CLINDAMYCIN PHOSPHATE | Sun Pharmaceutical Industries, Inc. | 5b8a6767-2d46-401c-9f85-d427dda9eff7 | 2026-04-24 | Warnings, Adverse reactions | EH6D7113I8 |
| Clindamycin Phosphate | CLINDAMYCIN PHOSPHATE | Bryant Ranch Prepack | c22fb382-afbc-4b2d-bdce-e97e21bddb23 | 2026-04-14 | Warnings, Adverse reactions | EH6D7113I8 |
| Clindacin ETZ | CLINDAMYCIN PHOSPHATE | Eurofarma, Inc. | 89fed26e-1cad-4c0b-8695-d6f3562ba8d5 | 2026-04-02 | Warnings, Adverse reactions | EH6D7113I8 |
| Clindamycin Phosphate | CLINDAMYCIN PHOSPHATE | Bryant Ranch Prepack | 34f7a271-c012-6463-e063-6394a90ad1ea | 2026-03-31 | Warnings, Adverse reactions | EH6D7113I8 |
| Clindamycin Phosphate | CLINDAMYCIN PHOSPHATE 1% | Preferred Pharmaceuticals Inc. | ea8d75ef-0e9b-4177-99f7-c901eb44f888 | 2026-03-30 | Warnings, Adverse reactions | EH6D7113I8 |
| Clindamycin Phosphate | CLINDAMYCIN PHOSPHATE | Preferred Pharmaceuticals Inc | e06d419f-4b60-405b-9459-e01bbb8d151d | 2026-03-30 | Warnings, Adverse reactions | EH6D7113I8 |
| CLINDAMYCIN PHOSPHATE | CLINDAMYCIN PHOSPHATE | Bryant Ranch Prepack | 311c05c2-a2b2-4051-b0b9-0427015aa980 | 2026-03-30 | Warnings, Adverse reactions | EH6D7113I8 |
| Clindamycin Phosphate | CLINDAMYCIN PHOSPHATE | Rising Pharma Holdings, Inc. | cc8262fe-8e41-49b2-97ae-7985e9a894e9 | 2026-03-24 | Warnings, Adverse reactions | EH6D7113I8 |
| Cleocin | CLINDAMYCIN PHOSPHATE | Pharmacia & Upjohn Company LLC | 3db26227-208d-4fdd-8426-1d9be5cda9b4 | 2026-03-09 | Warnings, Adverse reactions | EH6D7113I8 |
| Clindamycin Phosphate | CLINDAMYCIN PHOSPHATE | Bryant Ranch Prepack | 5c08f86e-abd7-4717-b902-74ea336ce28a | 2026-03-05 | Warnings, Adverse reactions | EH6D7113I8 |
| Clindamycin in 5 Percent Dextrose | CLINDAMYCIN IN 5 PERCENT DEXTROSE | Sandoz Inc | 231d95a6-5e5f-4a45-a92b-d3d16ef0a7ca | 2026-03-02 | Boxed warning, Warnings, Adverse reactions | 309336 309339 309335 |
| Clindamycin Phosphate | CLINDAMYCIN PHOSPHATE GEL USP, 1% | Encube Ethicals, Inc. | ac21d7ad-f94e-4d57-95e3-1648add7ad0b | 2026-02-25 | Warnings, Adverse reactions | EH6D7113I8 |
| XACIATO | CLINDAMYCIN PHOSPHATE | Organon LLC | 0423007f-28fa-4159-bf58-9174626d2347 | 2026-02-19 | Warnings, Adverse reactions | EH6D7113I8 |
| Clindamycin | CLINDAMYCIN PHOSPHATE | Henry Schein, Inc. | 8a4e2ba4-90e6-48e8-a943-0c5d3f169780 | 2026-02-18 | Boxed warning, Warnings, Adverse reactions | 1737581 1737578 1737244 EH6D7113I8 |
| Clindamycin Phosphate | CLINDAMYCIN PHOSPHATE USP, 1% | A-S Medication Solutions | 193a4b02-910f-46b2-8b61-25efea694720 | 2026-02-02 | Warnings, Adverse reactions | EH6D7113I8 |
| clindamycin and benzoyl peroxide | CLINDAMYCIN AND BENZOYL PEROXIDE | Glenmark Pharmaceuticals Inc., USA | 76795d1b-e1f2-4d1d-b42a-f1d4448c63c0 | 2026-01-31 | Warnings, Adverse reactions | EH6D7113I8 |
| Clindamycin Phosphate | CLINDAMYCIN PHOSPHATE | GLENMARK PHARMACEUTICALS INC., USA | d0ec3e88-40d9-4919-afc3-cf2e7e863376 | 2026-01-29 | Warnings, Adverse reactions | EH6D7113I8 |
| Clindamycin Phosphate | CLINDAMYCIN PHOSPHATE | E. Fougera & Co. a division of Fougera Pharmaceuticals, LLC | 997a23c8-f0d7-49d5-af33-e11f2ddab3c7 | 2026-01-28 | Warnings, Adverse reactions | EH6D7113I8 |
| Clindamycin Phosphate | CLINDAMYCIN PHOSPHATE | GLENMARK PHARMACEUTICALS INC., USA | d36bad26-f337-4a71-a6e5-d97b60f4e385 | 2026-01-28 | Warnings, Adverse reactions | EH6D7113I8 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.